Glimepiride and Exhaustion for Men aged 60+ (a phase IV clinical study of FDA data)

Summary:

Exhaustion is found for men aged 60+ who take Glimepiride (glimepiride). This study is created by eHealthMe based on reports of 12,829 men aged 60+ from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

  • Time on Glimepiride when people have Exhaustion
  • Top conditions
  • Top co-used drugs
  • Top other side effects


On Jun, 17, 2026

12,829 men aged 60+ reported to have side effects when taking Glimepiride.
Among them, 627 people (4.89%) have Exhaustion


What is Glimepiride?

Glimepiride has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 45,909 Glimepiride users. Check the latest studies of Glimepiride.

What is Exhaustion?

Exhaustion (tiredness) is found to be associated with 4,098 drugs and 6,455 conditions by eHealthMe. Check the latest studies of Exhaustion.

Number of reports submitted per year:

Could Glimepiride cause Exhaustion in men aged 60+?

Time on Glimepiride when people have Exhaustion *

  • < 1 month: 0.0 %
  • 1 - 6 months: 25.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 12.5 %
  • 2 - 5 years: 50.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 12.5 %

Severity of Exhaustion

n/a

How people recovered from Exhaustion

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

  1. High Blood Pressure: 77 people, 12.28%
  2. High Blood Cholesterol: 72 people, 11.48%
  3. Prostate Cancer: 50 people, 7.97%
  4. Multiple Myeloma (cancer of the plasma cells): 36 people, 5.74%
  5. Pain: 28 people, 4.47%
  6. Renal Cell Carcinoma (a kidney cancer): 22 people, 3.51%
  7. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 19 people, 3.03%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 18 people, 2.87%
  9. Cardiac Disorder: 18 people, 2.87%
  10. Depression: 15 people, 2.39%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

  1. Metformin: 171 people, 27.27%
  2. Aspirin: 74 people, 11.80%
  3. Amlodipine: 66 people, 10.53%
  4. Januvia: 64 people, 10.21%
  5. Vitamin B12: 47 people, 7.50%
  6. Lantus: 46 people, 7.34%
  7. Lisinopril: 45 people, 7.18%
  8. Vitamin D3: 43 people, 6.86%
  9. Tamsulosin: 42 people, 6.70%
  10. Lipitor: 41 people, 6.54%

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

  1. Nausea (feeling of having an urge to vomit): 126 people, 20.10%
  2. Weakness: 121 people, 19.30%
  3. Diarrhea: 107 people, 17.07%
  4. Dyspnea (difficult or laboured breathing): 95 people, 15.15%
  5. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 92 people, 14.67%
  6. Weight Decreased: 86 people, 13.72%
  7. Dizziness: 74 people, 11.80%
  8. Blood Glucose Increased: 65 people, 10.37%
  9. Headache (pain in head): 63 people, 10.05%
  10. Malaise (a feeling of general discomfort or uneasiness): 59 people, 9.41%

* Approximation only. Some reports may have incomplete information.

Do you take Glimepiride and have Exhaustion?

- Check whether Exhaustion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.



Related studies:

How the study uses the data?

The study is based on (applicable) gender, age, glimepiride (the active ingredients of Glimepiride) and Glimepiride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: